The Food and Drug Administration (FDA) approved the first COVID-19 vaccine on Monday August 23rd. The first vaccine to get FDA approval is the Pfizer-BioNTech COVID-19 Vaccine, marketed as Comirnaty. It is expected that FDA approval of the Moderna vaccine will follow. The FDA authorized booster shots for immunocompromised patients across the U.S. on August 12th. So far, more than 408 million doses have been delivered around the country. As Delta variant infections continue to increase, providers now have an added challenge — how to police people seeking unauthorized booster shots.
Per the Centers for Disease Control and Prevention (CDC), patients will start receiving a COVID-19 booster shot this fall, beginning the week of September 20, 2021, scheduling eight months after the individual’s second vaccine. However, more than 1.1 million people have already received an unauthorized third shot. These patients arrive at a facility requesting the vaccine. Because there is such a push for vaccinations, and vaccination sites have expanded to include drug stores, chain stores, and community centers, normal screening protocols might be missed.
In addition, the demand for COVID antibody drugs is soaring, especially in states hard hit by the virus. Monoclonal antibody treatments are antibody cocktails, which must be given within 10 days of COVID infection or exposure. Treatments are recommended for people at the highest risk of severe COVID-19, but according to a recent NPR article, regulators have broadened the list of those who can qualify. With expanded eligibility and skyrocketing caseloads across the U.S., more people are requesting these treatments.
The delta variant is putting America’s hospitals back in crisis mode. Hospital beds are at capacity, and clinicians and administrative staff are stretched to the breaking point. ICU beds are filled to or exceed capacity in at least 90 counties in the United States. COVID-19 has once again reminded us of the importance of “digital humans,” to take care of tasks without risk, illness, time off, or holidays.
How Can Boston WorkStation Help With The Vaccine Workflow?
RPA can uncover patient groups, verify, register, and schedule appointments, report lot numbers of vaccines registered, and queue up third dose follow-ups, or help to uncover those patients who qualify for antibody treatments.
RPA can create an encounter for the booster or monoclonal antibody treatments, at a specified date and time, and update the patient information in the EHR.
RPA can speed up the registration process, prior authorizations, rule validation, and help with HRSA claims for the uninsured patient populations.
RPA can be used with portal apps and patient charts to increase adoption of digital communication channels.
RPA can assist with vaccine supply chain management by automating special request allocations, integrating vial/batch data reporting, and manufacturer reporting.
Now more than ever, we all need to work together as a community to get through the unprecedented global challenges of this pandemic. We are ready to help by providing automation resources to organizations impacted by COVID-19, in an effort to maintain critical business continuity, during this unprecedented time. Customers who have implemented RPA solutions for these problems are feeling less of a pinch during this surge.
Why Boston Software Systems?
At Boston Software Systems, our exclusive focus is healthcare, and our project managers are experienced healthcare leaders. Let’s spend 30 minutes uncovering what can go live in < 30 days. We are shifting priorities so that organizations can quickly pivot to meet the demands of the new variant. With an overall KLAS vendor score of 90.8, we are a company dedicated to fast implementation timeframes, and excellent customer service.